Literature DB >> 10732818

The thermolabile variant of methylenetetrahydrofolate reductase (MTHFR) is not a major risk factor for neural tube defect in American Caucasians. The NTD Collaborative Group.

M C Speer1, G Worley, J F Mackey, E Melvin, W J Oakes, T M George.   

Abstract

Mutations in the gene for methylenetetrahydrofolate reductase (MTHFR) have been implicated as a risk factor in the formation of neural tube defects. We investigated this gene in a series of 65 sporadic American Caucasian patients with lumbosacral NTD and their unaffected parents, using both case-control design and assessment of linkage disequilibrium. We found no evidence to support mutations in MTHFR as a significant risk factor for NTD in this population.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 10732818     DOI: 10.1007/s100480050022

Source DB:  PubMed          Journal:  Neurogenetics        ISSN: 1364-6745            Impact factor:   2.660


  11 in total

1.  The "thermolabile" variant of methylenetetrahydrofolate reductase and neural tube defects: An evaluation of genetic risk and the relative importance of the genotypes of the embryo and the mother.

Authors:  D C Shields; P N Kirke; J L Mills; D Ramsbottom; A M Molloy; H Burke; D G Weir; J M Scott; A S Whitehead
Journal:  Am J Hum Genet       Date:  1999-04       Impact factor: 11.025

2.  A polymorphism, R653Q, in the trifunctional enzyme methylenetetrahydrofolate dehydrogenase/methenyltetrahydrofolate cyclohydrolase/formyltetrahydrofolate synthetase is a maternal genetic risk factor for neural tube defects: report of the Birth Defects Research Group.

Authors:  Lawrence C Brody; Mary Conley; Christopher Cox; Peadar N Kirke; Mary P McKeever; James L Mills; Anne M Molloy; Valerie B O'Leary; Anne Parle-McDermott; John M Scott; Deborah A Swanson
Journal:  Am J Hum Genet       Date:  2002-10-16       Impact factor: 11.025

Review 3.  Human neural tube defects: developmental biology, epidemiology, and genetics.

Authors:  Eric R Detrait; Timothy M George; Heather C Etchevers; John R Gilbert; Michel Vekemans; Marcy C Speer
Journal:  Neurotoxicol Teratol       Date:  2005-03-05       Impact factor: 3.763

4.  Folate receptor 1 is necessary for neural plate cell apical constriction during Xenopus neural tube formation.

Authors:  Olga A Balashova; Olesya Visina; Laura N Borodinsky
Journal:  Development       Date:  2017-03-02       Impact factor: 6.868

5.  Evaluation of a methylenetetrahydrofolate-dehydrogenase 1958G>A polymorphism for neural tube defect risk.

Authors:  Patrizia De Marco; Elisa Merello; Maria Grazia Calevo; Samantha Mascelli; Alessandro Raso; Armando Cama; Valeria Capra
Journal:  J Hum Genet       Date:  2005-11-29       Impact factor: 3.172

6.  Genetic association analyses of nitric oxide synthase genes and neural tube defects vary by phenotype.

Authors:  Karen L Soldano; Melanie E Garrett; Heidi L Cope; J Michael Rusnak; Nathen J Ellis; Kaitlyn L Dunlap; Marcy C Speer; Simon G Gregory; Allison E Ashley-Koch
Journal:  Birth Defects Res B Dev Reprod Toxicol       Date:  2013-12-09

7.  The methylenetethrahydrofolate reductase (MTHFR) C677T polymorphism and male infertility in Italy.

Authors:  L Stuppia; V Gatta; O Scarciolla; A Colosimo; P Guanciali-Franchi; G Calabrese; G Palka
Journal:  J Endocrinol Invest       Date:  2003-07       Impact factor: 4.256

8.  Variants in maternal COMT and MTHFR genes and risk of neural tube defects in offspring.

Authors:  Jufen Liu; Yali Zhang; Lei Jin; Guoxing Li; Linlin Wang; Yanping Bao; Yunting Fu; Zhiwen Li; Le Zhang; Rongwei Ye; Aiguo Ren
Journal:  Metab Brain Dis       Date:  2014-07-04       Impact factor: 3.584

Review 9.  "Polymorphisms in folate metabolism genes as maternal risk factor for neural tube defects: an updated meta-analysis".

Authors:  Upendra Yadav; Pradeep Kumar; Sushil Kumar Yadav; Om Prakash Mishra; Vandana Rai
Journal:  Metab Brain Dis       Date:  2014-07-09       Impact factor: 3.584

Review 10.  Folate action in nervous system development and disease.

Authors:  Olga A Balashova; Olesya Visina; Laura N Borodinsky
Journal:  Dev Neurobiol       Date:  2018-02-06       Impact factor: 3.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.